Wednesday, November 25, 2009, 1:46am SGT - The Singapore stock market opens in 7 hours and 14 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

STAAR Surgical Company (STAA)

At 1:31AM SGT: 3.7599 USD  Up 0.0099 (0.26%)  
 MORE ON STAA 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 STAAR Surgical Company (NGM:STAA) Delayed quote dataEdit
Last Trade:3.7599 USD
Trade Time:1:31AM SGT
Change:Up 0.0099 (0.26%)
Prev Close:3.75
Open:3.75
Bid:3.75 x 100
Ask:3.76 x 1900
1y Target Est:4.67
Day's Range:3.71 - 3.80
52wk Range:0.79 - 4.26
Volume:7,994
Avg Vol (3m):105,942
Market Cap:130.58M
P/E (ttm):N/A
EPS (ttm):-0.455
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add STAA to Portfolio   Download Data

 HEADLINES 
•STAAR SURGICAL CO Financials
EDGAR Online Financials (Wed, Nov 18)
•Cashing In on Obamacare
at Motley Fool (Sat, Nov 14)
•STAAR SURGICAL CO Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 13)
•STAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure
EDGAR Online (Tue, Nov 10)
•STAAR SURGICAL CO Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Sat, Nov 7)
•STAAR Surgical Earnings Call scheduled for 10:00 am ET today
CCBN (Tue, Nov 3)
•STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter
PR Newswire (Tue, Nov 3)
•Q3 2009 STAAR Surgical Earnings Release - After Market Close
CCBN (Mon, Nov 2)
•STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
PR Newswire (Wed, Oct 28)
•STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
PR Newswire (Tue, Oct 27)
More Headlines for STAA...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.18
EPS Est (in 2 years) (Dec-10) :0.05
Avg Rec (current)*:2.3
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
STAAR Surgical Company, together with its subsidiaries, develops, manufactures, and sells intraocular lenses (IOL), implantable collamer lenses (ICL), and ophthalmic surgical products used primarily in cataract and refractive surgery.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices